投稿ビュー
Langer's cell engineering immunotherapy play SQZ nabs $16M - FierceBiotech
FierceBiotech | Langer's cell engineering immunotherapy play SQZ nabs $16M FierceBiotech “Soon the real promise of their cell re-engineering technology will be applied across a variety of applications to treat a broad range of ailments," Amy Schulman, venture partner at Polaris and executive chair of SQZ, said in a statement. “I am ... |
投稿情報
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"